drugset / Trial / NCT00693576

The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates

NCT00693576

Phase 2/3 Completed 82 enrolled Shiraz University of Medical Sciences
NaSingle-groupOpen-labelTreatment

Summary

Patients with panel reactive antibodies have many difficulties to find a crossmatch-negative kidney for transplantation and are at the risk of post transplantation rejection more than other transplanted patients. We evaluated the effect of simvastatin on PRA and post transplant outcome of these sensitized patients. We also performed a descriptive study.

Timeline

Start
2007-04
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 20 mg

Indications

No indication recorded.